Related Experiment Video
Updated: Dec 21, 2025

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Nuclear receptor PXR targets AKR1B7 to protect mitochondrial metabolism and renal function in AKI
Xiaowen Yu1,2,3, Man Xu1,2,3, Xia Meng1,2,3
1Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing 210008, China.
Abstract:
Acute kidney injury (AKI) is a worldwide public health problem with no specific and satisfactory therapies in clinic. The nuclear pregnane X receptor (PXR) is involved in the progression of multiple diseases, including metabolic diseases, atherosclerosis, hypertension, liver injury, etc. However, its role in kidney injury remains to be understood. In this study, we have investigated the role of PXR in AKI and underlying mechanism(s) involved in its function. PXR was robustly down-regulated and negatively correlated with renal dysfunction in human and animal kidneys with AKI. Silencing PXR in rats enhanced cisplatin-induced AKI and induced severe mitochondrial abnormalities, whereas activating PXR protected against AKI. Using luciferase reporter assays, genomic manipulation, and proteomics data analysis on the kidneys of PXR-/- rats, we determined that PXR targeted Aldo-keto reductase family 1, member B7 (AKR1B7) to improve mitochondrial function, thereby ameliorating AKI. We confirmed the protective role of PXR against kidney injury using genomic and pharmacologic approaches in an ischemia/reperfusion model of AKI. These findings demonstrate that disabling the PXR/AKR1B7/mitochondrial metabolism axis is an important factor that can contribute to AKI, whereas reestablishing this axis can be useful for treating AKI.
Insights
Activating pregnane X receptor (PXR) protects against acute kidney injury (AKI) by targeting AKR1B7 to improve mitochondrial function. Disabling this pathway worsens kidney injury, suggesting therapeutic potential.
Area of Science:
- Nephrology
- Molecular Biology
- Biochemistry
Background:
- Acute kidney injury (AKI) is a significant global health issue lacking effective treatments.
- The role of the nuclear pregnane X receptor (PXR) in kidney injury is not well understood.
- PXR is implicated in various diseases, including metabolic disorders and liver injury.
Purpose of the Study:
- To investigate the role of PXR in the development and progression of AKI.
- To elucidate the underlying molecular mechanisms of PXR's function in kidney injury.
- To explore PXR as a potential therapeutic target for AKI.
Main Methods:
- Analysis of PXR expression in human and animal AKI models.
- In vivo studies involving PXR silencing and activation in rat models of AKI (cisplatin and ischemia/reperfusion).
- Luciferase reporter assays, genomic manipulation, and proteomics to identify PXR targets.
- Assessment of mitochondrial function and renal dysfunction.
Main Results:
- PXR expression was significantly downregulated in kidneys affected by AKI.
- PXR silencing exacerbated cisplatin-induced AKI and mitochondrial damage.
- PXR activation demonstrated a protective effect against AKI.
- PXR was identified to target Aldo-keto reductase family 1, member B7 (AKR1B7), enhancing mitochondrial function.
- Restoration of the PXR/AKR1B7/mitochondrial metabolism axis ameliorated kidney injury in both cisplatin and ischemia/reperfusion models.
Conclusions:
- The PXR/AKR1B7/mitochondrial metabolism axis plays a crucial role in protecting against AKI.
- Downregulation of this axis contributes to AKI pathogenesis.
- Re-establishing the PXR/AKR1B7 pathway offers a promising therapeutic strategy for AKI.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
15:43Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
PI3K/mTOR/AKT Signaling Pathway
Regulation of Nuclear Protein Sorting
Regulation of the Unfolded Protein Response
cAMP-dependent Protein Kinase Pathways
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...